已核实 DOI PubMed 相关产品: 1

Construction and Biocompatibility Evaluation of Fibroin/Sericin-Based Scaffolds

Journal 2022 · IF 5.395 · 发表于 2022 年 3 月 1 日
作者: Zexi Fu,Wenhui Li,Jingjing Wei,Ke Yao,Yuqing Wang,Pengxiang Yang,Guicai Li,Yumin Yang,Luzhong Zhang
阅读全文 在 PubMed 查看

摘要

Because tissue responses to implants determine the success or failure of tissue engineering products, fibroin/sericin-based scaffolds including bionic silk scaffolds, native silk fibers, fibroin fibers, and regenerated fibroin have been fabricated, and their biocompatibility was investigated. Fibroin/sericin-based scaffolds were characterized by scanning electron microscopy (SEM) and X-ray diffraction (XRD). Bionic silk scaffolds were beneficial to silk fiber formation through self-assembly. Histological and immunofluorescent staining analysis demonstrated that bionic silk scaffolds did not show significant inflammatory responses. Immunization analysis showed that soluble fibroin and sericin did not show obvious immunogenicity. This work supplied an effective approach to design fibroin/sericin-based scaffolds for tissue engineering and drug delivery.

本研究中使用的阿拉丁产品

1 款产品在本文中被引用